News

The latest news from Kindeva Drug Delivery

Explore the latest in combination products, biologics, and sustainability, and find out what’s new at Kindeva Drug Delivery.

Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives

November 12, 2024

Kindeva Drug Delivery Completes Registration Batch at State-of-the-Art Aseptic Injectable Fill-Finish Facility

October 8, 2024

Kindeva Drug Delivery’s Woodbury Analytical Services Site: Inspected by the FDA

July 16, 2024

Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialization

June 4, 2024

Kindeva Global Health Security Donates ATNAA to Ukraine Through the European Commission’s rescEU and Governmental Strategic Reserves Agency (RARS)

May 29, 2024

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award

May 8, 2024

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

May 6, 2024

Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations

April 18, 2024

Kindeva Drug Delivery and Syntegon install first Versynta microBatch in North America

April 9, 2024

Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services

March 18, 2024

Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

January 31, 2024

Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization

January 18, 2024
{{ x.card_name }}

{{ x.title }}

{{ x.date }}
Stay tuned for upcoming news!

Combine Forces With Kindeva

Bring Your Therapy to the World